Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-01 Option Award |
2024-01-03 4:15 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | Luptakova Katarina CHIEF MEDICAL OFFICER |
66,500 | $0 | 66,500 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 4:15 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 4:15 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | Russo Rene PRESIDENT AND CEO |
177,000 | $0 | 177,000 (Direct) |
View |
| 2023-09-05 Option Award |
2023-09-07 4:26 pm |
N/A 2033-09-04 |
Xilio Therapeutics Inc. | XLO | Luptakova Katarina Chief Medical Officer |
106,000 | $0 | 106,000 (Direct) |
View |
Ownership |
2023-09-07 4:23 pm |
N/A 2031-12-06 |
Xilio Therapeutics Inc. | XLO | Luptakova Katarina Chief Medical Officer |
0 | $0 | 119,210 (Direct) |
View |
| 2023-08-16 Option Award |
2023-08-18 8:45 pm |
N/A 2033-08-15 |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO |
700,000 | $0 | 700,000 (Direct) |
View |
| 2023-08-16 Option Award |
2023-08-18 8:40 pm |
N/A 2033-08-15 |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James CHIEF OPERATING OFFICER |
300,000 | $0 | 300,000 (Direct) |
View |
| 2023-08-16 Option Award |
2023-08-18 8:35 pm |
N/A 2033-08-15 |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-08-16 Option Award |
2023-08-18 8:30 pm |
N/A 2033-08-15 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D |
136,500 | $0 | 136,500 (Direct) |
View |
| 2023-08-03 Option Award |
2023-08-07 4:12 pm |
N/A 2033-08-02 |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Operating Officer |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2023-08-07 4:09 pm |
N/A 2031-03-28 |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Operating Officer |
0 | $0 | 398,172 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-13 4:30 pm |
N/A 2033-06-11 |
Xilio Therapeutics Inc. | XLO | ROSS ROBERT W. Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-13 4:30 pm |
N/A 2033-06-11 |
Xilio Therapeutics Inc. | XLO | Heyman Tomas J. Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-13 4:30 pm |
N/A 2033-06-11 |
Xilio Therapeutics Inc. | XLO | Xu Yuan Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-13 4:30 pm |
N/A 2033-06-11 |
Xilio Therapeutics Inc. | XLO | Bonstein Sara Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-13 4:30 pm |
N/A 2033-06-11 |
Xilio Therapeutics Inc. | XLO | Rossi Christina Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-13 4:30 pm |
N/A 2033-06-11 |
Xilio Therapeutics Inc. | XLO | Clancy Paul J Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-03 4:11 pm |
N/A 2033-03-31 |
Xilio Therapeutics Inc. | XLO | Brennan Kevin M. SVP, FINANCE AND ACCOUNTING |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-04 4:14 pm |
N/A 2032-12-31 |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO |
350,000 | $0 | 350,000 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-04 4:11 pm |
N/A 2032-12-31 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D |
136,500 | $0 | 136,500 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-04 4:09 pm |
N/A 2032-12-31 |
Xilio Therapeutics Inc. | XLO | English Edward C PRINCIPAL ACCOUNTING OFFICER |
24,000 | $0 | 24,000 (Direct) |
View |
Ownership |
2022-11-16 4:16 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | English Edward C Principal Accounting Officer |
0 | $0 | 79,399 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-16 4:15 pm |
N/A 2032-09-14 |
Xilio Therapeutics Inc. | XLO | Heyman Tomas J. Director |
26,400 | $0 | 26,400 (Direct) |
View |
| 2022-06-15 Option Award(A) |
2022-06-23 7:30 pm |
N/A 2032-06-14 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:31 pm |
N/A 2032-06-14 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:30 pm |
N/A 2032-06-14 |
Xilio Therapeutics Inc. | XLO | Rossi Christina Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:30 pm |
N/A 2032-06-14 |
Xilio Therapeutics Inc. | XLO | Ross Michael Jay Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:30 pm |
N/A 2032-06-14 |
Xilio Therapeutics Inc. | XLO | Clancy Paul J Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:30 pm |
N/A 2032-06-14 |
Xilio Therapeutics Inc. | XLO | Xu Yuan Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:30 pm |
N/A 2032-06-14 |
Xilio Therapeutics Inc. | XLO | Bonstein Sara Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:08 pm |
N/A 2032-06-14 |
Xilio Therapeutics Inc. | XLO | ROSS ROBERT W. Director |
26,400 | $0 | 26,400 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:30 pm |
N/A 2032-02-21 |
Xilio Therapeutics Inc. | XLO | Giovine Salvatore CHIEF FINANCIAL OFFICER |
49,500 | $0 | 49,500 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:30 pm |
N/A 2032-02-21 |
Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT OF R&D AND CMO |
65,000 | $0 | 65,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:30 pm |
N/A 2032-02-21 |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO AND PRESIDENT |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-06 6:48 pm |
N/A 2032-01-03 |
Xilio Therapeutics Inc. | XLO | Xu Yuan Director |
26,400 | $0 | 26,400 (Direct) |
View |
| 2021-12-22 Option Award(A) |
2022-01-04 5:32 pm |
N/A 2031-12-21 |
Xilio Therapeutics Inc. | XLO | Russo Rene CEO AND PRESIDENT |
100,000 | $0 | 100,000 (Direct) |
View |